Trial Profile
A phase I trial of IGF-methotrexate in patients with non-Hodgkin's lymphoma or metastatic prostate cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 27 Jul 2016
Price :
$35
*
At a glance
- Drugs IGF-methotrexate (Primary)
- Indications Non-Hodgkin's lymphoma; Prostate cancer
- Focus Adverse reactions
- Sponsors IGF Oncology
- 27 Jul 2016 New trial record